Metraipolis › archive › dc_dfd87b19dfd6

Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study — Europe PMC PMID:41757470

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41757470
DOI: 10.1158/2767-9764.crc-25-0633
License (as archived): solo-consultazione
Archived: 2026-10-07T22:58:09.046Z
SHA-256 of the archived text: 137dccc42af52494bbff4144771397faa319dc394770fd5572239931d2f84edd
Stable URL of this page: https://metraipolis.com/documento/dc_dfd87b19dfd6

How to cite

Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study — Europe PMC PMID:41757470 — Europe PMC (en), https://europepmc.org/article/MED/41757470 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dfd87b19dfd6 (Metraipolis archive dc_dfd87b19dfd6, sha256 137dccc42af52494bbff4144771397faa319dc394770fd5572239931d2f84edd)

BibTeX

@misc{dcdfd87b19dfd6,
  title = {Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study — Europe PMC PMID:41757470},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41757470},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dfd87b19dfd6; sha256 137dccc42af52494bbff4144771397faa319dc394770fd5572239931d2f84edd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41757470. Agents can read the archived copy with the MCP tool read_document.